Literature DB >> 6127460

Propranolol increases arterial ammonia in liver cirrhosis.

H R van Buuren, P C van der Velden, G Koorevaar, J Silberbusch.   

Abstract

Propranolol (20 mg 4 times a day) was given to patients with liver cirrhosis or fatty infiltration of the liver. In six patients with cirrhosis and a stable arterial plasma ammonia concentration before treatment, blood ammonia was increased significantly on day 3 of propranolol treatment. Arterial plasma ammonia concentration was still high on day 6 of propranolol. Individual percentage change in arterial ammonia ranged from 8% to 66%. After propranolol had been discontinued ammonia concentration returned to pretreatment concentrations in 3 to 6 days. In 3 patients with fatty livers and normal pretreatment ammonia concentrations no change was detected in arterial plasma ammonia while they were on propranolol.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6127460     DOI: 10.1016/s0140-6736(82)90158-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  7 in total

1.  The effect of propranolol on the rise in plasma ammonia during modest exercise.

Authors:  P E Hall; S R Smith; M J Kendall
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 2.  Medical treatment of portal hypertension and oesophageal varices.

Authors:  P C Hayes; A N Shepherd; I A Bouchier
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-10

3.  Endoscopic variceal pressure measurements: response to isosorbide dinitrate.

Authors:  J Dawson; P Gertsch; F Mosimann; R West; E Elias
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

4.  Effect of nadolol on liver haemodynamics and function in patients with cirrhosis.

Authors:  C Merkel; D Sacerdoti; G F Finucci; R Zuin; G Bazzerla; M Bolognesi; A Gatta
Journal:  Br J Clin Pharmacol       Date:  1986-06       Impact factor: 4.335

5.  Prophylaxis of first variceal hemorrhage in patients with liver cirrhosis.

Authors:  T Sauerbruch; G Kleber; A Gerbes; G Paumgartner
Journal:  Klin Wochenschr       Date:  1986-12-15

6.  Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension.

Authors:  P R Mills; A P Rae; D A Farah; R I Russell; A R Lorimer; D C Carter
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

7.  Long-term effect of nadolol on quantitative liver function tests in patients with cirrhosis.

Authors:  C Merkel; A Gatta; D Sacerdoti; M Bolognesi; M Rondana; L Caregaro; G F Finucci; A Ruol
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.